In an open letter to the U.S. Congress, the Pharmaceutical Research and Manufacturers of America (PhRMA), led by Stephen Ubl and including the board members of numerous major pharmaceutical companies, has expressed grave concerns regarding the Inflation Reduction Act of 2022. Merck is a PhRMA member.